Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Up 285.2% in May

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totaling 13,600 shares, a growth of 285.2% from the April 30th total of 3,531 shares. Based on an average daily volume of 81,908 shares, the short-interest ratio is currently 0.2 days.

Alpha Tau Medical Trading Down 6.4%

Alpha Tau Medical stock traded down $0.15 during midday trading on Friday, hitting $2.23. The stock had a trading volume of 16,684 shares, compared to its average volume of 55,695. Alpha Tau Medical has a 52-week low of $0.20 and a 52-week high of $2.99. The firm’s fifty day moving average is $1.35 and its two-hundred day moving average is $0.92.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.